Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine.

Fenoll A, Giménez MJ, Vicioso MD, Granizo JJ, Robledo O, Aguilar L.

J Antimicrob Chemother. 2009 Dec;64(6):1338-40. doi: 10.1093/jac/dkp376. Epub 2009 Oct 14. No abstract available.

PMID:
19828490
2.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

3.

Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.

Pantosti A, Boccia D, D'Ambrosio F, Recchia S, Orefici G, Moro ML; National Surveillance of Bacterial Meningitis; Earss-Italia Study.

Microb Drug Resist. 2003;9 Suppl 1:S61-8.

PMID:
14633369
4.

Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.

Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, Amin R, Fatima K, Brooks WA, Breiman RF, Sack DA, Luby SP; Pneumococcal Study Group.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S75-81. doi: 10.1086/596544.

PMID:
19191622
5.

Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.

Brandileone MC, Casagrande ST, Guerra ML, Zanella RC, Andrade AL, Di Fabio JL.

J Med Microbiol. 2006 May;55(Pt 5):567-74.

PMID:
16585644
6.

Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda.

Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E, Chaplain D, Nalumansi E, Mbabazi W, Gessner BD.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S153-61. doi: 10.1086/596495.

PMID:
19191611
7.

Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.

Traore Y, Tameklo TA, Njanpop-Lafourcade BM, Lourd M, Yaro S, Niamba D, Drabo A, Mueller JE, Koeck JL, Gessner BD.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S181-9. doi: 10.1086/596498.

PMID:
19191614
8.

Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009.

Gessner BD, Sanou O, Drabo A, Tamekloe TA, Yaro S, Tall H, Moïsi JC, Mueller JE, Njanpop-LaFourcade BM.

Vaccine. 2012 Dec 31;30 Suppl 6:G41-5. doi: 10.1016/j.vaccine.2012.10.052.

PMID:
23228357
9.

Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.

J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.

PMID:
18819966
10.

[Prevalence of serotypes and antimicrobial resistance of invasive strains of Streptococcus pneumoniae].

Mantese OC, Paula A, Moraes AB, Moreira TA, Guerra ML, Brandileone MC.

J Pediatr (Rio J). 2003 Nov-Dec;79(6):537-42. Portuguese.

11.

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007.

de O Menezes AP, Campos LC, dos Santos MS, Azevedo J, Dos Santos RC, Carvalho Mda G, Beall BW, Martin SW, Salgado K, Reis MG, Ko AI, Reis JN.

Vaccine. 2011 Feb 1;29(6):1139-44. doi: 10.1016/j.vaccine.2010.12.021. Epub 2010 Dec 21.

13.
14.

Invasive pneumococcal disease in HIV seropositive children and adolescents.

Mattei SM, Falleiros-Carvalho LH, Cavalcante NJ.

J Pediatr (Rio J). 2008 May-Jun;84(3):276-80. doi: doi:10.2223/JPED.1762.

15.

Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.

Paraskakis I, Kafetzis DA, Chrisakis A, Papavasilliou H, Kirikou H, Pangalis A, Tzouvelekis LS, Athanasiou T, Legakis NJ; National Surveillance Network for Pneumococcal Resistance.

Clin Microbiol Infect. 2006 May;12(5):490-3.

16.

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003.

Wasfy MO, Pimentel G, Abdel-Maksoud M, Russell KL, Barrozo CP, Klena JD, Earhart K, Hajjeh R.

J Antimicrob Chemother. 2005 Jun;55(6):958-64. Epub 2005 Apr 8.

PMID:
15820983
17.

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.

Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R.

J Clin Microbiol. 2013 Mar;51(3):820-7. doi: 10.1128/JCM.01917-12. Epub 2012 Dec 26.

18.

Streptococcus pneumoniae: a study of strains isolated from cerebrospinal fluid.

Vieira AC, Gomes MC, Rolo Filho M, Eudes Filho J, Bello EJ, de Figueiredo RB.

J Pediatr (Rio J). 2007 Jan-Feb;83(1):71-8. Epub 2007 Jan 23.

19.

Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain.

García-Suárez Mdel M, Villaverde R, Caldevilla AF, Méndez FJ, Vázquez F.

Jpn J Infect Dis. 2006 Oct;59(5):299-05.

20.

[Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients].

Firat M, Ersoy Y, Eşel D, Bayraktar M, Caylan R, Durmaz R.

Mikrobiyol Bul. 2006 Jul;40(3):169-77. Turkish.

PMID:
17001845

Supplemental Content

Support Center